Evidence map›Paper›PMID 40795898›Full record

ReviewCardiovascular research2025

A comprehensive review/expert statement on environmental risk factors of cardiovascular disease.

Thomas Münzel, Mette Sørensen, Jos Lelieveld, Philip J Landrigan, Marin Kuntic, Mark Nieuwenhuijsen, Mark R Miller, Alexandra Schneider, Andreas Daiber

Abstract readReview
In one paragraph

Review in Cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Characterization of 2-deoxyribose-5-phosphate aldolase from Bacillus altitudinis JYY-02.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thomas MünzelDepartment of Cardiology, University Medical Center Mainz, Johannes Gutenberg University, Langenbeckstrasse 1, Mainz 55131, Germany.ORCID 0000-0001-5503-4150
Mette SørensenWork, Environment and Cancer, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-7302-4789
Jos LelieveldAtmospheric Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.ORCID 0000-0001-6307-3846
Philip J LandriganGlobal Observatory on Planetary Health, Boston College, Boston, USA.
Marin KunticDepartment of Cardiology, University Medical Center Mainz, Johannes Gutenberg University, Langenbeckstrasse 1, Mainz 55131, Germany.ORCID 0000-0003-2435-851X
Mark NieuwenhuijsenInstitute for Global Health (ISGlobal), Barcelona, Spain.
Mark R MillerCentre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-7078-597X
Alexandra SchneiderInstitute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Andreas DaiberDepartment of Cardiology, University Medical Center Mainz, Johannes Gutenberg University, Langenbeckstrasse 1, Mainz 55131, Germany.ORCID 0000-0002-2769-0094

Funding

European Health and Digital Executive AgencyEuropean Union 101156161Foundation Heart of MainzScience Initiative of the state Rhineland-Palatinate, GermanySERISwiss State Secretariat for Education, Research and Innovation
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality globally, with over 20 million deaths each year. While traditional risk factors-such as hypertension, diabetes, smoking, and poor diet-are well-established, emerging evidence underscores the profound impact of environmental exposures on cardiovascular health. Air pollution, particularly fine particulate matter (PM2.5), contributes to approximately 8.3 million deaths annually, with over half attributed to CVD. Similarly, noise pollution, heat extremes, toxic chemicals, and light pollution significantly increase the risk of CVD through mechanisms involving oxidative stress, inflammation, and circadian disruption. Recent translational and epidemiological studies show that chronic exposure to transport noise increases the risk of myocardial infarction, stroke, and heart failure. Air pollution, even below regulatory thresholds, promotes atherosclerosis, vascular dysfunction, and cardiac events. Novel threats such as micro- and nano-plastics are emerging as contributors to vascular injury and systemic inflammation. Climate change exacerbates these risks, with heatwaves and wildfires further compounding the cardiovascular burden, especially among vulnerable populations. The cumulative effects of these exposures-often interacting with behavioural and socioeconomic risk factors-are inadequately addressed in current prevention strategies. The exposome framework offers a comprehensive approach to integrating lifelong environmental exposures into cardiovascular risk assessment and prevention. Mitigation requires systemic interventions including stricter pollution standards, noise regulations, sustainable urban design, and green infrastructure. Addressing environmental determinants of CVD is essential for reducing the global disease burden. This review calls for urgent policy action and for integrating environmental health into clinical practice to safeguard cardiovascular health in the Anthropocene.

Indexed as

Cardiovascular DiseasesEnvironmental ExposureAir PollutionAnimalsExposomeHeart Disease Risk FactorsHumansPrognosisRisk AssessmentRisk FactorsAir pollutionChemical pollutionEndothelial dysfunctionEnvironmentNoise exposureOxidative stressSoil and water pollution

Identifiers

PMID40795898
PMCPMC12477681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.